Litigation Details for CELGENE CORPORATION v. HIKMA PHARMACEUTICALS INTERNATIONAL LIMITED (D.N.J. 2018)
✉ Email this page to a colleague
CELGENE CORPORATION v. HIKMA PHARMACEUTICALS INTERNATIONAL LIMITED (D.N.J. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-08-31 |
| Court | District Court, D. New Jersey | Date Terminated | 2019-09-18 |
| Cause | 15:1126 Patent Infringement | Assigned To | Susan Davis Wigenton |
| Jury Demand | None | Referred To | Leda Dunn Wettre |
| Patents | 6,315,720; 6,561,977; 6,755,784; 6,869,399; 7,141,018; 7,230,012; 7,959,566; 8,315,886; 8,626,531 | ||
| Link to Docket | External link to docket | ||
Details for CELGENE CORPORATION v. HIKMA PHARMACEUTICALS INTERNATIONAL LIMITED (D.N.J. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-08-31 | 1 | Complaint | prior to the expiration of United States Patent Nos. 6,315,720 (the “’720 …140 PageID: 2 patent”), 6,561,977 (the “’977 patent”), 6,755,784 (the “’784 patent”), 6,869,399 (the…the “’399 patent”), 7,141,018 (the “’018 patent”), 7,230,012 (the “’012 patent”), 7,959,566 (the “’566…566 patent”), 8,315,886 (the “’886 patent”), and 8,626,531 (the “’531 patent”), all owned by Celgene … 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
